168 related articles for article (PubMed ID: 34637523)
1. Long-term good outcome of the fibrocavitary form of pulmonary Mycobacterium avium complex disease with concomitant abatacept monotherapy in a patient with rheumatoid arthritis.
Banno S; Yamaguchi E; Iwagaitsu S; Nobata H; Yamaguchi M; Sugiyama H; Kinashi H; Katsuno T; Kubo A; Ito S; Ito Y
Mod Rheumatol Case Rep; 2022 Jan; 6(1):1-5. PubMed ID: 34637523
[TBL] [Abstract][Full Text] [Related]
2. Successful resumption of tocilizumab for rheumatoid arthritis after resection of a pulmonary Mycobacterium avium complex lesion: a case report.
Namkoong H; Tasaka S; Akiyama M; Yagi K; Ishii M; Suzuki K; Kohno M; Hasegawa N; Takeuchi T; Betsuyaku T
BMC Pulm Med; 2015 Oct; 15():126. PubMed ID: 26496968
[TBL] [Abstract][Full Text] [Related]
3. Mycobacterium avium complex pulmonary disease: management options in HIV-negative patients.
Ramirez J; Mason C; Ali J; Lopez FA
J La State Med Soc; 2008; 160(5):248-54; quiz 254, 293. PubMed ID: 19048978
[TBL] [Abstract][Full Text] [Related]
4. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease.
Ye JJ; Wu TS; Chiang PC; Lee MH
J Microbiol Immunol Infect; 2007 Aug; 40(4):342-8. PubMed ID: 17712469
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of measuring antibodies to the glycopeptidolipid core antigen specific to Mycobacterium avium complex in patients with rheumatoid arthritis: results from a cross-sectional observational study.
Hirose W; Uchiyama T; Nemoto A; Harigai M; Itoh K; Ishizuka T; Matsumoto M; Yamaoka K; Nanki T
Arthritis Res Ther; 2015 Sep; 17():273. PubMed ID: 26415495
[TBL] [Abstract][Full Text] [Related]
6. [Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?].
Ogawa K; Sano C
Kekkaku; 2013 Mar; 88(3):355-71. PubMed ID: 23672176
[TBL] [Abstract][Full Text] [Related]
7. Chronic necrotizing pulmonary aspergillosis complicated by a cavitary lesion caused by Pulmonary Mycobacterium-avium complex disease.
Kobashi Y; Yoshida K; Miyashita N; Niki Y; Matsushima T
Intern Med; 2005 Mar; 44(3):246-50. PubMed ID: 15805716
[TBL] [Abstract][Full Text] [Related]
8. Development of Rheumatoid Arthritis in Cavitary
Tanaka H; Asakura T; Kikuchi J; Ishii M; Namkoong H; Kaneko Y; Fukunaga K; Hasegawa N
Infect Drug Resist; 2022; 15():91-97. PubMed ID: 35046674
[TBL] [Abstract][Full Text] [Related]
9. Difference in drug susceptibility distribution and clinical characteristics between
Wang W; Yang J; Wu X; Wan B; Wang H; Yu F; Guo Y
J Med Microbiol; 2021 May; 70(5):. PubMed ID: 33999797
[No Abstract] [Full Text] [Related]
10. Impact of chronic co-infection in pulmonary Mycobacterium avium complex disease after treatment initiation.
Urabe N; Sakamoto S; Shimanuki Y; Kanokogi T; Motohashi T; Anzai N; Kato C; Yamaguchi A; Tokita N; Homma S; Kishi K
BMC Pulm Med; 2022 Apr; 22(1):157. PubMed ID: 35468795
[TBL] [Abstract][Full Text] [Related]
11. Effective treatment for clarithromycin-resistant Mycobacterium avium complex lung disease.
Adachi Y; Tsuyuguchi K; Kobayashi T; Kurahara Y; Yoshida S; Kagawa T; Hayashi S; Suzuki K
J Infect Chemother; 2020 Jul; 26(7):676-680. PubMed ID: 32171660
[TBL] [Abstract][Full Text] [Related]
12. [Distribution of pulmonary Mycobacterium avium complex (MAC) disease cavities and their course under chemotherapy].
Kurashima A; Horibe M
Kekkaku; 2012 May; 87(5):397-402. PubMed ID: 22693873
[TBL] [Abstract][Full Text] [Related]
13. Natural history of
Hwang JA; Kim S; Jo KW; Shim TS
Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28275170
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for clinical progression in patients with pulmonary Mycobacterium avium complex disease without culture-positive sputum: a single-center, retrospective study.
Nonaka M; Matsuyama M; Sakai C; Matsumura S; Arai N; Nakajima M; Saito T; Hizawa N
Eur J Med Res; 2023 Jun; 28(1):186. PubMed ID: 37291649
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Mycobacterium avium Complex (MAC).
Griffith DE
Semin Respir Crit Care Med; 2018 Jun; 39(3):351-361. PubMed ID: 30071550
[No Abstract] [Full Text] [Related]
16. Comparison of the spectrum of radiologic and clinical manifestations of pulmonary disease caused by Mycobacterium avium complex and Mycobacterium xenopi.
Carrillo MC; Patsios D; Wagnetz U; Jamieson F; Marras TK
Can Assoc Radiol J; 2014 Aug; 65(3):207-13. PubMed ID: 24325924
[TBL] [Abstract][Full Text] [Related]
17. Early pulmonary resection for Mycobacterium avium complex lung disease treated with macrolides and quinolones.
Watanabe M; Hasegawa N; Ishizaka A; Asakura K; Izumi Y; Eguchi K; Kawamura M; Horinouchi H; Kobayashi K
Ann Thorac Surg; 2006 Jun; 81(6):2026-30. PubMed ID: 16731124
[TBL] [Abstract][Full Text] [Related]
18. The effect of combined therapy according to the guidelines for the treatment of Mycobacterium avium complex pulmonary disease.
Kobashi Y; Matsushima T
Intern Med; 2003 Aug; 42(8):670-5. PubMed ID: 12924489
[TBL] [Abstract][Full Text] [Related]
19. Long-term, low-dose erythromycin monotherapy for Mycobacterium avium complex lung disease: a propensity score analysis.
Komiya K; Kurashima A; Ihi T; Nagai H; Matsumoto N; Mizunoe S; Ishii H; Takahashi O; Ohta K; Kudoh S; Kadota J
Int J Antimicrob Agents; 2014 Aug; 44(2):131-5. PubMed ID: 24948577
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of intermittent maintenance therapy after successful treatment of Mycobacterium avium complex lung disease.
Asakura T; Nakagawa T; Suzuki S; Namkoong H; Morimoto K; Ishii M; Kurashima A; Betsuyaku T; Ogawa K; Hasegawa N;
J Infect Chemother; 2019 Mar; 25(3):218-221. PubMed ID: 30172726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
